These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15889127)

  • 1. Testosterone replacement therapy and the risk of prostate cancer: a perspective view.
    Barqawi AB; Crawford ED
    Int J Impot Res; 2005; 17(5):462-3. PubMed ID: 15889127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Barqawi A; Crawford ED
    Int J Impot Res; 2006; 18(4):323-8. PubMed ID: 16281043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy and prostate cancer.
    Morgentaler A
    Urol Clin North Am; 2007 Nov; 34(4):555-63, vii. PubMed ID: 17983895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Heaton JP
    Can J Urol; 2002 Dec; 9(6):1677-80. PubMed ID: 12517308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and prostate cancer: what are the risks for middle-aged men?
    Morgentaler A
    Urol Clin North Am; 2011 May; 38(2):119-24. PubMed ID: 21621078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy in hypogonadal men and prostate cancer risk.
    Kirby R; Gould D
    BJU Int; 2005 Sep; 96(4):471-2. PubMed ID: 16104891
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterpoint: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Casey RW
    Can J Urol; 2002 Dec; 9(6):1681-3. PubMed ID: 12517309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts regarding the relationship of testosterone and prostate cancer.
    Morgentaler A
    Future Oncol; 2007 Apr; 3(2):123-6. PubMed ID: 17381410
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy: a dangerous elixir?
    Pearson H
    Nature; 2004 Sep; 431(7008):500-1. PubMed ID: 15457228
    [No Abstract]   [Full Text] [Related]  

  • 13. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
    Harman SM
    Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic prostate cancer after orchiectomy, radiotherapy, and testosterone replacement in a patient with bilateral seminoma.
    Manassero F; Erba P; Mariani G; Mogorovich A; Giannarini G; Selli C
    J Androl; 2007; 28(1):10-2. PubMed ID: 16899814
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
    Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of androgen supplementation therapy on the prostate.
    Kaufman JM
    Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.